Capecitabine, Bevacizumab, and Radiation Therapy Followed By Gemcitabine and Bevacizumab in Treating Patients With Locally Advanced Pancreatic Cancer That Cannot Be Removed By Surgery

Clinical trial NCT00114179 · COMPLETED

Trial details

NCT number: NCT00114179
Sponsor: National Cancer Institute (NCI)
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Adenocarcinoma of the Pancreas Stage II Pancreatic Cancer Stage III Pancreatic Cancer

Start date: 2005-01-01
Primary completion: 2007-05-01
Enrollment: 82

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.